UK HealthTech Ready To Take The Digital Challenge With Focused Actions
Executive Summary
Digital tools and maximizing the data derived from them will influence the delivery of health care in ways and to extents yet unknown. Andrew Davies, market access director for UK industry group ABHI, explains the industry's planning around this, and calls for a rethink on innovation market access structures, which are still failing to meet industry's needs.
You may also be interested in...
The New Culture Club: UK NHS Goes Upstream For Care Delivery And Offers New Chances For Medtechs
Hopes are high for the NHS Long Term Plan’s ability to transform health-care delivery and make a potentially unsustainable service fit for the future. There are opportunities for diagnostics, devices and digital providers, but are the resources there to turn the Plan into a success story?
Latest UK Political Shenanigans: What Medtech Needs To Know
Theresa May finally made a Brexit plan, but its effects have been explosive. One consequence: the UK has a new health secretary. What do the latest cabinet changes mean for health products, and why is certainty still so far away?
Brexit Trade Deal Must Wait, But UK Medtech Sector Finds Reasons To Be Cheerful
During the week of the ostensibly pivotal EU Summit on Brexit, the UK government has made the EU27 wait for its white paper on proposed post-EU trading arrangements. The UK medtech industry, in turn, is kept waiting on its EU future. But far from remaining idle, manufacturers are focusing on innovation adoption and working with the NHS, where there is a new sense of purpose, and maybe a light at the end of the tunnel.